784822005: Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorised by disposition\Adrenergic receptor antagonist-containing product\Beta blocker-containing product\Timolol-containing product\Timolol-containing product in ocular dose form\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Medicinal product categorised by disposition\Adrenergic receptor antagonist-containing product\Beta blocker-containing product\Timolol-containing product\Brimonidine- and timolol-containing product\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Medicinal product categorised by disposition\Adrenergic receptor antagonist-containing product\Beta blocker-containing product\Timolol-containing product\Brimonidine- and timolol-containing product\Brimonidine and timolol only product\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Medicinal product categorised by disposition\Adrenergic receptor agonist-containing product\Alpha adrenergic receptor agonist-containing product\Alpha-2 adrenergic receptor agonist-containing product\Brimonidine-containing product\Brimonidine-containing product in ocular dose form\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Medicinal product categorised by disposition\Adrenergic receptor agonist-containing product\Alpha adrenergic receptor agonist-containing product\Alpha-2 adrenergic receptor agonist-containing product\Brimonidine-containing product\Brimonidine- and timolol-containing product\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Medicinal product categorised by disposition\Adrenergic receptor agonist-containing product\Alpha adrenergic receptor agonist-containing product\Alpha-2 adrenergic receptor agonist-containing product\Brimonidine-containing product\Brimonidine- and timolol-containing product\Brimonidine and timolol only product\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution

\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Azole-containing product\Imidazole-containing product\Brimonidine-containing product\Brimonidine-containing product in ocular dose form\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Azole-containing product\Imidazole-containing product\Brimonidine-containing product\Brimonidine- and timolol-containing product\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Azole-containing product\Imidazole-containing product\Brimonidine-containing product\Brimonidine- and timolol-containing product\Brimonidine and timolol only product\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Timolol-containing product\Timolol-containing product in ocular dose form\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Timolol-containing product\Brimonidine- and timolol-containing product\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Timolol-containing product\Brimonidine- and timolol-containing product\Brimonidine and timolol only product\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Medicinal product categorised by structure\Alcohol-containing product\Timolol-containing product\Timolol-containing product in ocular dose form\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Medicinal product categorised by structure\Alcohol-containing product\Timolol-containing product\Brimonidine- and timolol-containing product\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Medicinal product categorised by structure\Alcohol-containing product\Timolol-containing product\Brimonidine- and timolol-containing product\Brimonidine and timolol only product\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution

\Medicinal product categorised by therapeutic role\Antiglaucoma agent\...

\Brimonidine-containing product in ocular dose form\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution

\Timolol-containing product in ocular dose form\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution

\Product manufactured as ocular dose form\Brimonidine-containing product in ocular dose form\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Product manufactured as ocular dose form\Timolol-containing product in ocular dose form\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution

\Autonomic agent\Sympathomimetic-containing product\Adrenergic receptor agonist-containing product\Alpha adrenergic receptor agonist-containing product\Alpha-2 adrenergic receptor agonist-containing product\Brimonidine-containing product\Brimonidine-containing product in ocular dose form\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Autonomic agent\Sympathomimetic-containing product\Adrenergic receptor agonist-containing product\Alpha adrenergic receptor agonist-containing product\Alpha-2 adrenergic receptor agonist-containing product\Brimonidine-containing product\Brimonidine- and timolol-containing product\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Autonomic agent\Sympathomimetic-containing product\Adrenergic receptor agonist-containing product\Alpha adrenergic receptor agonist-containing product\Alpha-2 adrenergic receptor agonist-containing product\Brimonidine-containing product\Brimonidine- and timolol-containing product\Brimonidine and timolol only product\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Autonomic agent\Beta blocker-containing product\Timolol-containing product\Timolol-containing product in ocular dose form\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Autonomic agent\Beta blocker-containing product\Timolol-containing product\Brimonidine- and timolol-containing product\Brimonidine- and timolol-containing product in ocular dose form\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution
\Autonomic agent\Beta blocker-containing product\Timolol-containing product\Brimonidine- and timolol-containing product\Brimonidine and timolol only product\Brimonidine and timolol only product in ocular dose form\Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution

Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3765547014 Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core

3765548016 Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution en Synonym Active Initial character case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Plays role	Antiglaucoma therapeutic role	true	Inferred relationship	Some
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	2
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Has manufactured dose form	Eye solution	true	Inferred relationship	Some
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	1
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Has concentration strength denominator value	1	false	Inferred relationship	Some	1
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Count of base of active ingredient	2	false	Inferred relationship	Some
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Has concentration strength denominator value	1	false	Inferred relationship	Some	2
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	1
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Is a	Brimonidine and timolol only product in ocular dose form	true	Inferred relationship	Some
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Has concentration strength numerator value	5	false	Inferred relationship	Some	1
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Has concentration strength numerator value	2	false	Inferred relationship	Some	2
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Has BoSS	Brimonidine tartrate	true	Inferred relationship	Some	2
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Has BoSS	Timolol	true	Inferred relationship	Some	1
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Has precise active ingredient	Timolol	true	Inferred relationship	Some	1
Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	Has precise active ingredient	Brimonidine tartrate	true	Inferred relationship	Some	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Unit of use size reference set

Description inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3765547014	Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
3765548016	Brimonidine tartrate 2 mg/mL and timolol 5 mg/mL eye solution	en	Synonym	Active	Initial character case insensitive	SNOMED CT core